Literature DB >> 24827544

When and for how long should glucocorticoids be used in rheumatoid arthritis? International guidelines and recommendations.

Cécile Gaujoux-Viala1, Laure Gossec.   

Abstract

Glucocorticoids are widely used in rheumatoid arthritis (RA); however, their effectiveness and safety is still a subject of debate. In particular, when to introduce glucocorticoids, but also when and how to taper them, are important questions for clinicians. In this paper, we will discuss the place of glucocorticoids in the European League Against Rheumatism (EULAR) recommendations for the management of RA and review the literature that was the basis for these recommendations. The recommendations cover the introduction of glucocorticoids (and for whom they are recommended), doses and duration of treatment, and tapering strategies. Items still on the research agenda include more data on safety, particularly for long-term use, and small doses of glucocorticoids.
© 2014 New York Academy of Sciences.

Entities:  

Keywords:  EULAR; glucocorticoids; inflammation; recommendations; rheumatoid arthritis

Mesh:

Substances:

Year:  2014        PMID: 24827544     DOI: 10.1111/nyas.12452

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

Review 1.  [Long-term glucocorticoid therapy : Is there a safe dosage?].

Authors:  C Strehl; F Buttgereit
Journal:  Internist (Berl)       Date:  2016-09       Impact factor: 0.743

2.  Enhanced therapeutic anti-inflammatory effect of betamethasone on topical administration with low-frequency, low-intensity (20 kHz, 100 mW/cm(2)) ultrasound exposure on carrageenan-induced arthritis in a mouse model.

Authors:  Gadi Cohen; Hiba Natsheh; Youhan Sunny; Christopher R Bawiec; Elka Touitou; Melissa A Lerman; Philip Lazarovici; Peter A Lewin
Journal:  Ultrasound Med Biol       Date:  2015-05-21       Impact factor: 2.998

3.  Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis - the TryCort study.

Authors:  Uta Kiltz; Christine von Zabern; Xenofon Baraliakos; Frank Heldmann; Bernd Mintrop; Michael Sarholz; Dietmar Krause; Friedrich Dybowski; Ludwig Kalthoff; Jürgen Braun
Journal:  Arthritis Res Ther       Date:  2017-04-07       Impact factor: 5.156

4.  Intra-articular Injection of Baicalein Inhibits Cartilage Catabolism and NLRP3 Inflammasome Signaling in a Posttraumatic OA Model.

Authors:  Hui Bai; Rui Yuan; Zhiheng Zhang; Lin Liu; Xinyu Wang; Xiaopeng Song; Tianwen Ma; Jilang Tang; Chunpeng Liu; Li Gao
Journal:  Oxid Med Cell Longev       Date:  2021-09-02       Impact factor: 6.543

5.  The efficacy of low dose short-term prednisone therapy for remission induction in newly diagnosed rheumatoid arthritis patients.

Authors:  John M Stacy; Jacob R Greenmyer; James R Beal; Abe E Sahmoun; Erdal Diri
Journal:  Adv Rheumatol       Date:  2021-08-09

Review 6.  Glucocorticoids in rheumatoid arthritis: current status and future studies.

Authors:  Charlotte Hua; Frank Buttgereit; Bernard Combe
Journal:  RMD Open       Date:  2020-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.